Skip to main content

Advertisement

Log in

Synchronous bilateral breast cancer in a male patient following hormone therapy for prostate cancer

  • Case Report
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

We report an unusual case of bilateral, synchronous breast cancer in a male patient who had a history of estrogen therapy for prostate cancer. A 64-year-old Japanese man was diagnosed with T1N0M0 prostate cancer and received a total prostatectomy. Twenty months after the resection, the patient developed multiple bone metastases, and received radiation therapy, systemic chemotherapy, and hormone therapy for 15 months. After completing this treatment, he was diagnosed with T1N0M0 primary breast cancer in his left breast and underwent a modified mastectomy. Five months after the mastectomy he received systemic chemotherapy followed by estrogen therapy because of the progression of prostate cancer. Three months after this treatment, he was diagnosed with T1N0M0 primary breast cancer in his right breast. To the best of our knowledge, this is a rare case of synchronous bilateral male breast cancer following hormone therapy for prostate cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Weiss JR, Moysich KB, Swede H (2005) Epidemiology of male breast cancer. Cancer Epidemiol Bilmarkers Prev 14:20–26

    Google Scholar 

  2. Narod SA, Offit K (2005) Prevention and management of hereditary breast cancer. J Clin Oncol 23:1656–1663

    Article  PubMed  Google Scholar 

  3. Cutuli BF (2007) Strategies in treating male breast cancer. Expert Opin Pharmacother 8:193–202

    Article  PubMed  CAS  Google Scholar 

  4. Swedlow AJ, Shoemaker MJ, Higgins CD, et al. (2005) Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J Natl Cancer Inst 97:1204–1210

    Article  Google Scholar 

  5. Tischkowitz MD, Hodgson SV, Fentiman IS (2002) Male breast cancer: etiology, genetics and clinical management. Int J Clin Pract 56:750–754

    PubMed  CAS  Google Scholar 

  6. Levi F, Lucchini F, Vecchia CL (2002) Epidemiology of male breast cancer. Eur J Cancer Prev 11:315–318

    Article  PubMed  CAS  Google Scholar 

  7. Giordano SH, Buzdar AU, Hortobagyi GN (2002) Breast cancer in men. Ann Int Med 137:678–687

    PubMed  Google Scholar 

  8. El-Gazayerli MM, Abdel-Aziz AS (1963) On bilateral and male breast cancer in Egypt: a preliminary report and review of literature. Br J Cancer 17:566–571

    PubMed  CAS  Google Scholar 

  9. Olsson H, Ranstam J (1988) Head trauma and exposure to prolactin-elevating drugs as risk factors for male breast cancer. J Natl Cancer Inst 80:679–683

    Article  PubMed  CAS  Google Scholar 

  10. Karamanakos P, Apostolopoulos V, Fafauliotis S, et al. (1996) Synchronous bilateral primary male breast carcinoma with hyperprolactinoma. Acta Oncol 35:757–759.

    Article  PubMed  CAS  Google Scholar 

  11. Volm MD, Talamanti MS, Thangavelu M, et al. (1997) Pituitary adenoma and bilateral male breast cancer: an unusual association. J Surg Oncol 64:74–78

    Article  PubMed  CAS  Google Scholar 

  12. Hsing AW, Chakkalingam AP (2006) Prostate cancer epidemiology. Front Biosci 11:1388–1413

    Article  PubMed  CAS  Google Scholar 

  13. Fetiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet 367:595–604

    Article  Google Scholar 

  14. Valeri A, Fournier G, Morin B, et al. (2000) Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. Int J Cancer 86:883–887

    Article  PubMed  CAS  Google Scholar 

  15. Stratton MR, Ford D, Neuhausen S, et al. (1994) Familial breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet 7:103–107

    Article  PubMed  CAS  Google Scholar 

  16. Aarason A, Barkardottir RB, Egilsson V (1993) Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. Am J Hum Genet 52:711–719

    Google Scholar 

  17. Simpson E, Rubin G, Clyne C, et al. (1999) Local estrogen biosynthesis in males and females. Endocr Relat Cancer 6:131–137

    Article  PubMed  CAS  Google Scholar 

  18. Labrie F, Luu-The V, Lin SX, et al. (2000) Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and diseases. J Mol Endocrinol 25:1–16

    Article  PubMed  CAS  Google Scholar 

  19. Mahler C, Berhelst J, Denis L (1998) Clinical pharmacokinetics of the antiandrogens and their efficacy in prostate cancer. Clin Pharmacokinet 34:405–417

    Article  PubMed  CAS  Google Scholar 

  20. Potosky AL, Knopf K, Clegg LX, et al. (2001) Quality-of-life outcomes after primary androgen deprivation therapy: results from the prostate cancer outcomes study. J Clin Oncol 19:3750–3757

    PubMed  CAS  Google Scholar 

  21. Kolvenbag GJ, Iversen P, Newling DW (2001) Antiandgrogen monotherapy: a new form of treatment for patients with prostate cancer. Urology 58:16–23

    Article  PubMed  CAS  Google Scholar 

  22. Sobin LH, Sherif M (1980) Relation between male breast cancer and prostate cancer. Br J Cancer 42:787–790

    PubMed  CAS  Google Scholar 

  23. Schoenenberg BS (1977) Multiple primary malignancies. The Connecticut experience, 1935–1964. Recent results Cancer Res 58:1–173

    Google Scholar 

  24. Tellenberg C, Malmer B, Wiklund F, Gronberg H (2006) Breast cancer as a second primary in patients with prostate cancer — estrogen treatment or association with family history of cancer? J Urol 176:538–543

    Article  Google Scholar 

  25. Symmers W (1968) Carcinoma of breast in transsexual individuals after surgical and hormonal interference with primary and secondary sex characteristics. BMJ 2:83–85

    Article  PubMed  CAS  Google Scholar 

  26. Pritchard TJ, Pankowsky DA, Crowe JP, et al. (1988) Breast cancer in a male to female transsexual. JAMA 259:2278–2280

    Article  PubMed  CAS  Google Scholar 

  27. Bounds WE, Burton GV, Schwalke MA (1993) Male breast cancer. J La State Med Soc 145:353–356

    PubMed  CAS  Google Scholar 

  28. Coard K, McCartney T (2004) Bilateral synchronous carcinoma of the male breast in a patient receiving estrogen therapy for carcinoma of the prostate: cause or coincidence? Southern Med J 97:308–310

    Article  PubMed  Google Scholar 

  29. Howard RR, Grosjean WA, Kan W (1949) Bilateral mammary carcinoma in the male coincident with prolonged stilbestrol therapy. Surgery 25:300–303

    PubMed  CAS  Google Scholar 

  30. McClure JA, Higgins CC (1951) Bilateral carcinoma of male breast after estrogen therapy. JAMA 146:7–9

    CAS  Google Scholar 

  31. Emoto A, Nasu N, Mimata H, et al. (2001) A male case of primary bilateral breast cancers during estrogen therapy for prostate cancer (in Japanese). Nippon Hinyokika Gakkai Zasshi 92:698–701

    PubMed  CAS  Google Scholar 

  32. Staerkle RF, Lenzlinger PM, Suter SL, et al. (2006) Synchronous bilateral ductal carcinoma in situ of the male breast associated with gynecomastia in a 30-year-old patient following repeated injections of stanozolol. Breast Cancer Res Treat 97:173–176

    Article  PubMed  Google Scholar 

  33. Katz RL, Raval P, Brooks TE, Ordonez NG (1985) Role of immunocytochemistry in diagnosis of prostatic neoplasia by fine-needle aspiration biopsy. Diagn Cytopathol 1:28–32

    Article  PubMed  CAS  Google Scholar 

  34. Yu H, Diamandis EP, Sutherland DJA (1994) Immunoreactive prostate specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 27:75–79

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuko Kijima.

About this article

Cite this article

Kijima, Y., Yoshinaka, H., Hirata, M. et al. Synchronous bilateral breast cancer in a male patient following hormone therapy for prostate cancer. Int J Clin Oncol 14, 249–253 (2009). https://doi.org/10.1007/s10147-008-0824-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-008-0824-9

Key words

Navigation